The updated WHO treatment guidelines recommend that drug-resistant TB be treated with oral drugs only, including newer, more potent drugs with fewer side effects.

Advocates call for minimizing the use of injectable agents and scaling up universal drug susceptibility testing.

Advocates call for removal of regulatory barriers, which contributed to the ongoing national stock out of GeneXpert MTB/RIF cartridges.

The World Health Organization has revamped its Civil Society Task Force on TB to strengthen collaboration for accelerating progress towards ending TB.

The petition will be delivered to the Heads of States and Governments prior to the next Global Fund replenishment conference in October 2019.

Global funding for TB research climbed to a previously unreported high of USD $772 million in 2017.

IT'S TIME... to get ready for World TB Day 2019!

Médecins Sans Frontières calls on Global Fund Board to make urgent changes to prevent drug stock-outs and quality issues.

Activists urge the Global Fund and donors to take prompt action to address the grave risks posed to countries that are rapidly shifting from pooled procurement of TB medicines and commodities.

Activists urge international donors and country governments to ensure access to quality health products as domestic financing policies push programs to the edge of procurement cliff.